Article info

Download PDFPDF
Augmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCD

Authors

  • Joseph O'Neill Division of Child and Adolescent Psychiatry, UCLA Semel Institute for Neurosciences, University of California, Los Angeles, California, USA; PubMed articlesGoogle scholar articles

Citation

O'Neill J
Augmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCD

Publication history

  • First published April 8, 2014.
Online issue publication 
April 23, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.